Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20200428005
TCTR20200428005
Completed
未知

Prognostic parameter in patients having therapy-related myeloid neoplasms after peptide receptor radionuclide therapy (PRRT) and peptide receptor radioligand therapy (PRLT) over 20 years’ experience

one0 sites386 target enrollmentApril 28, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionstherapy&#45related myeloid neoplasmpeptide receptor radionuclide therapyrelated myeloid neoplasm&#44prognostic factor&#44peptide receptor radionuclide therapy&#44overall survival&#44predictor&#44myelodysplastic syndrome

Overview

Phase
未知
Intervention
Not specified
Conditions
therapy&#45
Sponsor
one
Enrollment
386
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 28, 2020
End Date
September 30, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • •Patients who had therapy\-related myeloid neoplasm after receiving peptide receptor radionuclide therapy and peptide receptor radioligand therapy

Exclusion Criteria

  • •Patient under 18 years old

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Online-interventions against depression. Exploring predictors of treatment outcome.
ACTRN12614000312640Freie Universitaet Berlin500
Completed
Not Applicable
Evaluation of prognostic factors for patients undergoing surgical resection for pancreatic cancer after pre-operative therapies, a retrospective study.Pancreatic cancer
JPRN-UMIN000027346Yokohama city university, school of medicine Dept of Gastroenterological Surgery500
Completed
Not Applicable
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter StudyThe study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailandhigh risked neuroblastoma&#44topotecan&#44induction therapy&#44treatment response&#44prognostic factor&#44treatment&#45related toxicity
TCTR20190602002Phramongkutklao Hospital and College of Medicine107
Completed
Not Applicable
Prognostic Factors for treatment and follow-up of patients after colorectal surgerychemo- en radiotherapeutische voorbehandelingseffecten op maagdarm neoplasmatacolorectal cancergut cancer1001799110017998
NL-OMON31685Atrium Medisch Centrum400
Not yet recruiting
Not Applicable
nderstanding clinical aspects of Guillain Barre SyndromeHealth Condition 1: G610- Guillain-Barre syndrome
CTRI/2024/04/065303Dr Rahul Kurade